The FDA’s Advisory Committee will meet in open session to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified.
The meeting will include slide presentations with audio components to allow the presentation of materials in a manner that most closely resembles an in-person advisory committee meeting.
When/Where: 8:30 a.m. – 5:00 p.m. EST, Tuesday, June 28, 2022 (Online)
For more information and to participate, visit the FDA’s website.